[go: up one dir, main page]

MacLoughlin et al., 2024 - Google Patents

Performance Characterisation of the Airvo2TM Nebuliser Adapter in Combination with the Aerogen SoloTM Vibrating Mesh Nebuliser for in Line Aerosol Therapy …

MacLoughlin et al., 2024

View HTML
Document ID
425700226021537183
Author
MacLoughlin R
Mac Giolla Eain M
Publication year
Publication venue
Pharmaceutics

External Links

Snippet

High flow oxygen (HFO) therapy is a well-established treatment in respiratory disease. Concurrent aerosol delivery can greatly expediate their recovery. The aim of this work was to complete a comprehensive characterisation of one such HFO therapy system, the Airvo2TM …
Continue reading at www.mdpi.com (HTML) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/10—Preparation of respiratory gases or vapours
    • A61M16/105—Filters
    • A61M16/106—Filters in a path
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/0003—Accessories therefor, e.g. sensors, vibrators, negative pressure
    • A61M2016/003—Accessories therefor, e.g. sensors, vibrators, negative pressure with a flowmeter
    • A61M2016/0033—Accessories therefor, e.g. sensors, vibrators, negative pressure with a flowmeter electrical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/08—Bellows; Connecting tubes ; Water traps; Patient circuits
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
    • G06Q50/10—Services
    • G06Q50/22—Health care, e.g. hospitals; Social work
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00—Measuring parameters of the user
    • A61M2230/40—Respiratory characteristics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/0057—Pumps therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof

Similar Documents

Publication Publication Date Title
McGrath et al. Investigation of the quantity of exhaled aerosols released into the environment during nebulisation
McGrath et al. Investigation of fugitive aerosols released into the environment during high-flow therapy
Yıldız-Peköz et al. Advances in pulmonary drug delivery
Alcoforado et al. Impact of gas flow and humidity on trans-nasal aerosol deposition via nasal cannula in adults: a randomized cross-over study
Li et al. The ratio of nasal cannula gas flow to patient inspiratory flow on trans-nasal pulmonary aerosol delivery for adults: an in vitro study
Joyce et al. Nebuliser type influences both patient-derived bioaerosol emissions and ventilation parameters during mechanical ventilation
Williams et al. In vitro anatomical models for nasal drug delivery
Adorni et al. Aerosolization performance of jet nebulizers and biopharmaceutical aspects
Naughton et al. Evaluation of aerosol drug delivery options during adult mechanical ventilation in the COVID-19 era
Liu et al. Size distribution of colistin delivery by different type nebulizers and concentrations during mechanical ventilation
Lindert et al. Performance of dry powder inhalers with single dosed capsules in preschool children and adults using improved upper airway models
Fernandez Fernandez et al. Evaluation of aerosol therapy during the escalation of care in a model of adult cystic fibrosis
Lin et al. In vitro evaluation of a vibrating-mesh nebulizer repeatedly use over 28 days
Borojeni et al. In silico quantification of intersubject variability on aerosol deposition in the oral airway
Bianco et al. Extended pharmacopeial characterization of surfactant aerosols generated by a customized eflow neos nebulizer delivered through neonatal nasal prongs
Tai et al. Nebulised isotonic hydroxychloroquine aerosols for potential treatment of COVID-19
Bianco et al. In vitro performance of an investigational vibrating-membrane nebulizer with surfactant under simulated, non-invasive neonatal ventilation conditions: Influence of continuous positive airway pressure interface and nebulizer positioning on the lung dose
Chen et al. Compatible stability and aerosol characteristics of Atrovent®(ipratropium bromide) mixed with salbutamol sulfate, terbutaline sulfate, budesonide, and acetylcysteine
Li et al. Bronchodilator delivery via high-flow nasal cannula: a randomized controlled trial to compare the effects of gas flows
Gemci et al. CFD study of dry pulmonary surfactant aerosols deposition in upper 17 generations of human respiratory tract
Fernández-Parra et al. Salbutamol transport and deposition in the upper and lower airway with different devices in cats: a computational fluid dynamics approach
Gallagher et al. The impact of head model choice on the in vitro evaluation of aerosol drug delivery
DiBlasi et al. Evaluation of a novel dry powder surfactant aerosol delivery system for use in premature infants supported with bubble CPAP
Vega Pittao et al. Home high-flow therapy in patients with chronic respiratory diseases: physiological rationale and clinical results
Liu et al. Optimization of vibrating mesh nebulizer air inlet structure for pulmonary drug delivery